A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease
De Vivo I,
Rimm E B,
Hotamisligil G S
Proceedings of the National Academy of Sciences of the United States of America (2006).